AI Note-Taking Startup Abridge Raises $300M As Tech To Reduce Physician Burnout Gains Traction

Abridge

, a startup that offers an AI note-taking tool for doctors, raised $300 million at a $5.3 billion valuation, according to The Wall Street Journal. Andreessen Horowitz led the Series E round for the Pittsburgh- and San Francisco-based startup, with Khosla Ventures joining. Several well-funded startups have emerged to try to reduce the doctor burnout associated with note-taking and other administrative duties. “We’ve seen healthcare take up generative AI-centered solutions faster than any other industry,” Abridge CEO and co-founder Dr. Shiv Rao told the Journal. His startup’s technology works by using ambient-listening technology to tune into conversations between doctors and patients and automatically transcribe notes, reducing the after-hours time physicians spend on administrative tasks. Along with Abridge — which has now raised $757.5 million total from investors, per Crunchbase — other well-funded startups in the AI healthcare documentation space include:

  • Nabla, which has a note-taking AI copilot for doctors and other medical staff earlier this month raised $70 million in Series C funding, bringing its total raised to $114.7 million;
  • CodaMetrix, an AI-driven medical coding platform that has raised $95 million in total funding;
  • Regard, another AI-driven physician note-taking tool that has raised more than $81.42 million; and
  • Freed, an AI clinician assistant designed to reduce time spent by health care professionals on documentation that has raised $30 million over time.

Overall, funding to startups at the intersection of AI and healthcare hit $7.5 billion in 2024. This year is on pace to top that, with $5.6 billion invested through late June, per Crunchbase data.

Related Crunchbase queries:

Related reading:

Illustration: Dom Guzman

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Tags

More Related Articles

Info icon

This data feed is not available at this time.

Data is currently not available

Sign up for the TradeTalks newsletter to receive your weekly dose of trading news, trends and education. Delivered Wednesdays.